NASDAQ NMS - GLOBAL MARKET · INM
-9.04% · -$0.1500 · Vol 19.1K
Market closed · last close 4:00 PM ET · price as of 16:11:15 ET
InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc

Pharmaceuticals
$1.51
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is INM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for INM are being assembled.
About InMed Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
13
Country
CA

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.65
Day high
$1.67
Day low
$1.61
Previous close
$1.66
52W high
$1.67
-9.58% from high
52W low
$1.51
0% of range
Market cap
$5.4M
EPS
$-3.6200
Shares out
5.3M
Volume
19.1K
VWAP
$1.66
Price history computed in-house
SMA 50 $1.51 · above
SMA 200 $1.51 · above
52W position 0%
Veridion warehouse edge

Warehouse intelligence for INM.

Veridion Score
59
0: 851: 432: 923: Not reported4: Not reported5: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

INM insider activity

InMed Pharmaceuticals Inc

Score
Coverage building
Pressure
Net buying
Filings
27
Buys / sells
27 / 0
Net value
$1.1M
Insiders
3
Named filers
VL
Vivo Opportunity, LLC
Insider
Leadership
VL
Vivo Opportunity Cayman Fund, L.P.
Insider
Leadership
SD
Schneeberger Daniel
Insider
Leadership
Cluster

3 insiders bought in the last 90 days

Net pressure

Net buying: $1.1M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-07-022026-07-02Vivo Opportunity, LLCInsiderbuy$1.5514773,135$228SEC Form 4
2026-07-022026-07-02Vivo Opportunity, LLCInsiderbuy$1.551,460724,395$2KSEC Form 4
2026-07-022026-07-01Vivo Opportunity, LLCInsiderbuy$1.5539872,988$617SEC Form 4
2026-07-022026-07-01Vivo Opportunity, LLCInsiderbuy$1.553,946722,935$6KSEC Form 4
2026-07-022026-06-30Vivo Opportunity, LLCInsiderbuy$1.545572,590$85SEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 22 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

INM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INM in this window.
Lobbying spend

INM lobbying filings, year to date.

Registered lobbying filings matched to InMed Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INM in this window.
Latest news · INM
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for INM.
Options
Sovereign unlock shows live options positioning for INM.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.